ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-OR042

Exercise Cardiac MRI and Cardiopulmonary Testing Reveal Distinct Exercise Phenotypes and Dynamic Cardiac Impairment in CKD: CRUISE-CKD Study

Session Information

Category: Hypertension and CVD

  • 1602 Hypertension and CVD: Clinical

Authors

  • Dobre, Mirela A., University Hospitals Health System, Cleveland, Ohio, United States
  • Glidden, Michael D, University Hospitals Health System, Cleveland, Ohio, United States
  • Kwun, Audrey, University Hospitals Health System, Cleveland, Ohio, United States
  • Pollard, Jordan T, University Hospitals Health System, Cleveland, Ohio, United States
  • Jenkins, Trevor L, University Hospitals Health System, Cleveland, Ohio, United States
  • Cara, Elaine Ann, Case Western Reserve University, Cleveland, Ohio, United States
  • Vergara-Martel, Armando, Case Western Reserve University, Cleveland, Ohio, United States
  • Makhlouf, Mohamed, University Hospitals Health System, Cleveland, Ohio, United States
  • Al-Kindi, Sadeer, Houston Methodist, Houston, Texas, United States
  • Rajagopalan, Sanjay, University Hospitals Health System, Cleveland, Ohio, United States
Background

Dyspnea and exercise limitation are common in patients with CKD, yet the underlying mechanisms remain poorly understood. We developed a novel non-contrast exercise cardiac magnetic resonance (MR) imaging protocol combined with cardiopulmonary testing (ECMR-CPT) using an MR-compatible recumbent bike, to characterize structural and functional cardiac responses during acute exertion in CKD.

Methods

The CRUISE-CKD study prospectively enrolled 14 patients with CKD stages 3–4 (mean eGFR 32.6 ± 6.7 mL/min/1.73m2), and no history of heart failure. Participants underwent ECMR-CPT with measurement of biventricular volumes, systolic and diastolic function, pulmonary pressures, myocardial T1/T2 mapping (surrogates for fibrosis and edema), and cardiopulmonary metrics (maximum O2 consumption [VO2max], and ratio minute ventilation to CO2 consumption [VE/VCO2]) at rest and immediately post exercise.

Results

With exercise, significant increases were observed in left ventricle (LV) stroke volume (+12.7 mL), LV ejection fraction (EF) (+6.9%), cardiac output (+3.1 L/min), with marked inter-individual variability in biventricular response. Average VO2max improved by +6.64 ml/kg/min (mean peak 9.21 ml/kg/min), and the mean VE/VCO2 slope was 8.2, suggesting impaired ventilatory efficiency. Myocardial T1 values were elevated at rest, indicating subclinical fibrosis. T1 elevations and blunted right ventricle (RV) reserve with exertion were common and associated with lower VO2max. Two patients demonstrated exaggerated right heart response and signs suggestive of early exercise-induced pulmonary hypertension. A third of participants showed impaired contractile reserve and abnormal pulmonary hemodynamics during stress. Overall, ECMR-CPT revealed three distinct phenotypes: (1) preserved ejection fraction with impaired diastolic reserve, (2) RV-pulmonary vascular uncoupling, and (3) skeletal muscle-dominant limitation with preserved cardiac response.

Conclusion

Mechanisms beyond reduced GFR contribute to exercise intolerance in CKD. Our study highlights the value of dynamic imaging to reveal cardiac dysfunction not evident at rest and inform phenotype-guided interventions to improve functional outcomes in CKD.

Funding

  • Private Foundation Support

Digital Object Identifier (DOI)